Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women

IMPORTANCE: Data on BNT162b2 messenger RNA (mRNA) vaccine (Pfizer-BioNTech) effectiveness and safety in pregnancy are currently lacking because pregnant women were excluded from the phase 3 trial. OBJECTIVE: To assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2021-08, Vol.326 (8), p.728-735
Hauptverfasser:	Goldshtein, Inbal, Nevo, Daniel, Steinberg, David M, Rotem, Ran S, Gorfine, Malka, Chodick, Gabriel, Segal, Yaakov
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adverse events Age BNT162 Vaccine Case-Control Studies Comments Confidence Intervals COVID-19 - epidemiology COVID-19 - immunology COVID-19 - prevention & control COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - adverse effects COVID-19 Vaccines - immunology Drug dosages Exposure Female Gestational Age Headache Health hazards Health risks Humans Immunization Incidence Infections Influenza Israel - epidemiology Kaplan-Meier Estimate mRNA mRNA vaccines Online First Original Investigation Pain Polymerase chain reaction Pregnancy Pregnancy Complications, Infectious - epidemiology Pregnancy Complications, Infectious - immunology Pregnancy Complications, Infectious - prevention & control Pregnant Women Regression Analysis Residential areas Retrospective Studies Risk Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Subgroups Time Factors Vaccination Vaccination - statistics & numerical data Vaccines Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!